Biostar Pharmaceuticals Inc (BSPM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 12,174 | 17,382 | 10,490 | 6,690 | N/A |
| Depreciation Amortization | 885 | 620 | 600 | 640 | N/A |
| Income taxes - deferred | -300 | N/A | N/A | N/A | N/A |
| Accounts receivable | -5,332 | -8,057 | N/A | N/A | N/A |
| Other Working Capital | -8,524 | -6,029 | -6,820 | -8,110 | N/A |
| Other Operating Activity | 9,871 | 8,926 | 1,400 | 10 | 0 |
| Operating Cash Flow | $8,773 | $12,841 | $5,670 | $-770 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -111 | -1,732 | -1,040 | -50 | N/A |
| Net Acquisitions | -4,038 | N/A | 0 | 0 | N/A |
| Other Investing Activity | -2,191 | -6,806 | -2,480 | -270 | 0 |
| Investing Cash Flow | $-6,340 | $-8,538 | $-3,520 | $-320 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,122 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | 38 | N/A | N/A | N/A |
| Other Financing Activity | -335 | 0 | 5,670 | -540 | 0 |
| Financing Cash Flow | $787 | $38 | $5,670 | $-540 | $N/A |
| Exchange Rate Effect | 540 | 292 | 0 | 120 | N/A |
| Beginning Cash Position | 13,211 | 8,578 | 750 | 2,280 | N/A |
| End Cash Position | 16,972 | 13,211 | 8,570 | 750 | N/A |
| Net Cash Flow | $3,760 | $4,634 | $7,810 | $-1,520 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,773 | 12,841 | 5,670 | -770 | N/A |
| Capital Expenditure | -111 | -1,732 | N/A | N/A | N/A |
| Free Cash Flow | 8,663 | 11,110 | 5,670 | -770 | 0 |